Position in SCLX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$1,931
-$1,606 QoQ
Shares Held
290
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026KLP KAPITALFORVALTNING AS holds $1,266,100,784 across 11 Drug Manufacturers - General names. SCLX ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
317,879 | $292,375,567 | |
| 2 | JNJ |
Johnson & Johnson
|
1,089,714 | $266,369,690 | |
| 3 | ABBV |
AbbVie Inc.
|
798,372 | $173,637,926 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,196,870 | $143,971,492 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
718,408 | $100,124,522 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,591,658 | $96,534,057 | |
| 7 | PFE |
Pfizer Inc
|
2,983,732 | $83,783,194 | |
| 8 | AMGN |
Amgen Inc
|
205,876 | $72,437,470 |
All Filings in SCLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,931 | 290 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,537 | 290 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,707 | 290 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,708 | 290 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,542 | 10,212 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||